Meryem AKTAN, Gul KANYİLMAZ, Berrin BENLİ YAVUZ

Intramedullary spinal cord metastasis and radiotherapy

Aim: Intramedullary spinal cord metastasis (ISCM) is a rare but a severe condition. We aimed to evaluate the clinical features, the effect of radiotherapy on the functional results, and the quality of life and survival in patients with ISCM.Material andMethods: We retrospectively assessed the results of 15 patients. Patients underwent 3D conformal radiotherapy (3D-CRT). Patients were reviewed in terms of neurological deficits, the localization of primary tumors, the duration of symptoms, onset symptoms, the localization of ISCM,and the interval between diagnosis and spinal metastasis. Post-radiotherapy outcomes and factors influencing the survival and the quality of life were analyzed.Results: The mean duration of symptoms before diagnosis was 14.93 days (range; 1-52 days).The most common presenting symptoms of patients were lower back and back pain. Neurological deficit was present in 9 patients. Of these patients, partial improvement was observed following the radiotherapy in four patients. After the radiotherapy, the need of painkillers and pain were decreased in 10 of the patients with pain at the outset (66.7%). An association was detected between the initiation of radiotherapy within 10 days from the onset of symptoms and the quality of life (p=0.026).The mean survival rate was 5.9 months after being diagnosed with ISCM.Conclusions: Motor deficit and pain-related quality of life were corrupted in most of the patients with ISCM. Early diagnosis and suitable treatment might promote to the functional condition of the patient. It is important to initiate radiotherapy within a period of less than 10 days from the onset of symptoms.

PDF

___

Minomo S, Tokoro A, Utsumi T, et al. A case of long-term survival after multimodal local treatments of intramedullary spinal cord metastasis of squamous cell lung cancer. J Thorac Dis 2016;8: E681-3.
Gren JL, Burgess J, Trump DL. Clinical features and natural history of intramedullary spinal cord metastases. Cancer 1985; 56:2305-14.
Katsenos S, Nikolopoulou M. Intramedullary thoracic spinal metastasis from small-cell lung cancer. Monaldi Arch Chest Dis 2013;79:140-2.
Sahli M, Hemmaoui B, Benariba F. Intramedullary spinal cord metastasis from laryngeal carcinoma: case report and review of literature. Pan Afr Med J 2017;26:189.
Hashii H, Mizumoto M, Kanemoto A, et al. Radiotherapy for patients with symptomatic intramedullary spinal cord metastases. J Radiat Res 2011;52:641-5.
Sung WS, Sung MJ, Chan JH, et al. Intramedullary spinal cord metastases: a 20-year institutional experience with a comprehensive literature review. World Neurosurg 2013;79:576-84.
Schiff D, O’Neill BP. Intramedullary spinal cord metastases: clinical features and treatment outcome. Neurology 1996;47:906-12.
Mostardi PM, Diehn FE, Rykken JB, et al. Intramedullary spinal cord metastases: visibility on PET and correlation with MRI features. AJNR Am J Neuroradiol 2014;35:196-201.
Faugeras L, Cantineau G, Daisne JF, et al. Intramedullary spinal cord metastasis of cholangiocarcinoma: a case report. BMC Res Notes 2015;8:41.
Basaran R, Tiryaki M, Yavuzer D, et al. Spinal intramedullary metastases of breast cancer. Case Rep Med 2014;2014:583282.
Lee SS, Kim MK, Sym SJ, et al. Intramedullary spinal cord metastases: a single-institution experience. J Neurooncol 2007;84: 85-9.
Dam-Hieu P, Seizeur R, Mineo JF, et al. Retrospective study of 19 patients with intramedullary spinal cord metastasis. Clin Neurol Neurosurg 2009;111:10-7.
Hrabalek L. Intramedullary spinal cord metastases: review of the literature. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010;154:117-22.
Yang KH, Lee HR, Yi SY, et al. Intramedullary spinal cord metastases from rectal cancer. Ann coloproctol 2014;30:237-40.
Kalaycı M, Cağavi F, Gül S, et al. Intramedullary spinal cord metastases: diagnosis and treatment-an illustrated review. Acta Neurochir (Wien) 2004;146: 1347-54.